For researchers publishing data or tracking precise outcomes, batch consistency is not optional
Liraglutide and sitagliptin have no effect on intestinal microbiota composition: a 12-week randomized placebo-controlled trial in adults with type 2 diabetes
Dysregulation of GLP-1R signaling contributes to impaired insulin secretion, altered lipid homeostasis, hyperglycemia, and metabolic dysfunction observed in obesity and type 2 diabetes [1]
Do not start, stop, or change a prescription medicine based on this article or an isolated laboratory result
Injection site reactions are uncommon but can include temporary redness, itching, or mild swelling
Retatrutide is different: it does not currently have an FDA-approved brand name or generic product because it remains investigational